You'd expect tripling your caffeine dose to triple the fat-burning payoff. A new randomized trial suggests the opposite: the biggest dose did the least for fat oxidation, and the smallest dose that worked was the one that spared the heart.
The Study in 30 Seconds
Researchers led by Gong, publishing in the Journal of the International Society of Sports Nutrition, tested caffeine in a small group of overweight or obese, sedentary female college students. Eleven participants (average age 20.2, BMI 26.36 kg/m²) completed four sessions: placebo (cellulose) or caffeine at 3, 5, or 9 mg per kg of body weight (PubMed 42120324).
Each session had 60 minutes of seated rest, then 40 minutes of treadmill walking at FATmax, the intensity where the body burns the most fat. Indirect calorimetry tracked fuel use. Blood pressure, heart rate, and fingertip perfusion index (PI) tracked the cardiovascular response.
The Headline Finding: More Was Not Better
Both 3 and 5 mg/kg increased fat oxidation compared with placebo and with the 9 mg/kg dose (p < 0.05). The 9 mg/kg dose gave no added metabolic benefit, according to the authors.
Carbohydrate oxidation moved in the same direction. It was lower with 5 mg/kg than with placebo. Both the 3 and 5 mg/kg doses showed lower carbohydrate oxidation than the 9 mg/kg dose. Put simply, the moderate doses shifted fuel use toward fat, and the highest dose did not.
Caffeine did not change resting heart rate or substrate oxidation. The fat-burning effect showed up during exercise, not while sitting still.
The Catch: Your Heart Noticed
The cardiovascular data is where the story changes.
- 3 mg/kg: no significant cardiovascular effects during exercise.
- 5 mg/kg: significantly higher heart rate and blood pressure during exercise.
- 9 mg/kg: also significantly higher heart rate and blood pressure.
- All caffeine doses: PI decreased (p < 0.05). PI is a fingertip measure of peripheral perfusion.
The authors concluded that 3 mg/kg offers the best balance between stimulating fat oxidation and keeping cardiovascular strain down in this population. The 5 mg/kg dose raised fat oxidation too, but at the cost of extra cardiovascular strain.
Practical Takeaways
Dose. The tested sweet spot was 3 mg/kg. As an illustration, a 70 kg person would get about 210 mg of caffeine. The 5 mg/kg dose works out to about 350 mg, and the 9 mg/kg dose to about 630 mg. That is simple arithmetic, not a figure from the paper.
Timing. In the protocol, participants rested for 60 minutes after taking the capsule before a 40-minute walk. That is the only timing the data supports. The abstract does not say whether participants were fasted, so "fasted cardio" is not something this study can confirm.
Intensity. The exercise was walking at FATmax, a measured, moderate-intensity zone. The results should not be assumed to apply to hard intervals or long endurance sessions.
Who it may suit. The findings apply to sedentary, overweight or obese young women doing acute, low-intensity exercise. That is the group tested.
Who should be cautious or skip it. The abstract does not test people with heart or blood pressure problems. Because 5 and 9 mg/kg raised heart rate and blood pressure during exercise, anyone with hypertension or a cardiac condition, or anyone sensitive to caffeine, should talk to a clinician before experimenting. Skipping the higher doses is a sensible reading of this data for everyone.
Reality Check: What This Study Can't Tell You
This is a very small trial. Eleven participants is not enough to say the result holds across populations, and the data comes from one group of young women. Men, athletes, older adults, and people who use caffeine habitually were not studied, and the abstract does not mention habitual caffeine intake.
The study is also acute. It measured a single session, not weeks of training. Higher fat oxidation during a 40-minute walk does not mean more body fat lost over time, and the paper does not claim that. Fuel use during exercise is not the same as fat loss outcomes.
The PI drop across all caffeine doses is worth noting, but the abstract does not explain what it means clinically. Treat it as a signal that caffeine had measurable vascular effects, not as proof of harm.
Bottom Line
In this small randomized trial, 3 mg/kg of caffeine gave a fat-oxidation boost over placebo without the heart rate and blood pressure rise seen at higher doses. The 9 mg/kg dose added no metabolic benefit. The study supports a modest, body-weight-based dose rather than a bigger one, while leaving open questions about long-term results and other populations.
Source: Gong et al., Journal of the International Society of Sports Nutrition. DOI: 10.1080/15502783.2026.2670558.